Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACH 2
2024-515663-59-00Phase 3Authorised
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Keppra prophylaxis with Placebo (2 arms). Primary endpoint: Functional status by modified Rankin Scale at 6 months. Planned start Apr 2026; status: authorised.
02
Drugs
levetiracetam
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2024-515663-59-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515663-59-00.